A premier gathering of global experts, innovators, and leaders advancing the science and application of mRNA technology.
Welcome to The
mRNA Conference 2026 - a premier gathering of global experts, innovators, and leaders advancing the science and application of mRNA technology. Over two dynamic days, we explore the transformative potential of
mRNA vaccines and therapeutics - from breakthroughs in infectious disease prevention to cutting-edge treatments for rare and chronic conditions. Join us in Barcelona this October to connect, collaborate, and shape the future of RNA medicine.
6 Key Themes for the mRNA Conference 2026
- Innovations in mRNA Vaccine Development: Cutting-edge advances in vaccine design for infectious diseases and cancer.
- mRNA Therapeutics Beyond Vaccines: Exploring protein replacement, autoimmune, and rare disease treatments.
- Delivery Systems & Formulation Technologies: Next-generation lipid nanoparticles, stability, and novel administration routes.
- Manufacturing & Scalability: Rapid, cost-effective production methods and global manufacturing solutions.
- Regulatory Pathways & Clinical Translation: Navigating approvals, trial design, safety, and real-world implementation.
- Global Access & Equity: Addressing distribution challenges and ensuring vaccines and therapies reach all populations.
Who Should Attend
- Researchers & Scientists: Focused on RNA biology, immunology, and drug delivery
- Biotech & Pharma Professionals: R&D, clinical development, manufacturing, and regulatory affairs
- Investors & Venture Capitalists: Looking for emerging RNA technologies and startups
- Healthcare Providers & Clinicians: Interested in latest vaccine and therapeutic applications
- Policy Makers & Regulators: Shaping frameworks for RNA-based medicine approval and access
- Global Health Organizations & NGOs: Working to expand equitable access worldwide
Industries Represented
- Vaccines & Immunotherapies
- Genetic Medicine & RNA Therapeutics
- Drug Delivery & Nanotechnology
- Clinical Research & Healthcare
- Pharmaceutical Manufacturing
- Investment & Venture Capital
- Global Health & Policy
2026 Speakers
- Eric HALIOUA, President & Chief Executive Officer PDC*line Pharma
- Christopher P. Locher, CEO and co-founder Versatope Therapeutics
- Kinkini Roy, Associate Director, Formulation Development AVICEDA THERAPEUTICS INC
- Ilya Vensky, General Partner Provisio Ventures
- Lélia Delamarre, Distinguished Scientist in Oncology Discovery Genentech.
- Sean Bedingfield, Senior Advisor Eli Lilly & Co
- Dr. Angelo Amabile, Professor in the Department of Immunology and Immunotherapy Icahn School of Medicine at Mount Sinai.
- Nagy Habib, Professor of Hepatobiliary Surgery Department of Surgery & Cancer - Faculty of Medicine Imperial College London
- Dr. Bowen Li, Assistant Professor at the Leslie Dan Faculty of Pharmacy University of Toronto and the Canada Research Chair in RNA Vaccines & Therapeutics.
- Husain Attarwala, Vice President of Bioanalytics, DMPK, Clinical Pharmacology, Analytics Aera Therapeutics
- Dr. Muthiah Manoharan, Senior Vice President of Drug Innovation, Scientific Advisory Board Member Alnylam Distinguished Research Scientist Alnylam Pharmaceuticals
- Professor Neill Liptrott, Chair in Pharmacology & Immunocompatibility Pharmacology & Therapeutics University of Liverpool
- James Lee, Senior Director, Business Development Everest Medicines
- Jane Luo, Senior Scientist, Cell and Gene Therapy Applications, Strategic Technical Marketing, SCIEX
- Dr Prasun Chakraborty, CEO and Founder Genevation
- Gilles DIVITA, Cofounder and CEO Divincell SAS
- Craig Martin, Co-founder, CSO Waterfall Scientific
- Steve Pascolo, Senior Scientist, Department of Dermatology University Hospital Zurich
- Kyungjin Peter Kim, President & CEO Samyang Group
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Hotel SB Plaza Europa
Carrer de les Ciències 11, 13, L’Hospitalet de Llobregat, 08908
Barcelona, Spain
